Levels	O
of	O
the	O
soluble	O
LDL	B:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
LR11	I:C1307867
decrease	O
in	O
overweight	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
upon	O
diet	O
-	O
induced	O
weight	O
loss	O
.	O

Levels	O
of	O
the	O
soluble	O
LDL	O
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
LR11	I:C1307867
decrease	O
in	O
overweight	O
individuals	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
upon	O
diet	O
-	O
induced	O
weight	O
loss	O
.	O

Cardiovascular	B:C0007222
disease	I:C0007222
(	O
Cardiovascular	O
disease	I:C0007222
)	O
is	O
a	O
major	O
complication	O
in	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
,	O
especially	O
in	O
those	O
with	O
obesity	O
.	O

Cardiovascular	O
disease	I:C0007222
(	O
Cardiovascular	B:C0007222
disease	I:C0007222
)	O
is	O
a	O
major	O
complication	O
in	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
,	O
especially	O
in	O
those	O
with	O
obesity	O
.	O

Cardiovascular	O
disease	I:C0007222
(	O
Cardiovascular	O
disease	I:C0007222
)	O
is	O
a	O
major	O
complication	B:C0009566
in	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
,	O
especially	O
in	O
those	O
with	O
obesity	O
.	O

Cardiovascular	O
disease	I:C0007222
(	O
Cardiovascular	O
disease	I:C0007222
)	O
is	O
a	O
major	O
complication	O
in	O
patients	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
,	O
especially	O
in	O
those	O
with	O
obesity	O
.	O

Cardiovascular	O
disease	I:C0007222
(	O
Cardiovascular	O
disease	I:C0007222
)	O
is	O
a	O
major	O
complication	O
in	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
)	O
,	O
especially	O
in	O
those	O
with	O
obesity	O
.	O

Cardiovascular	O
disease	I:C0007222
(	O
Cardiovascular	O
disease	I:C0007222
)	O
is	O
a	O
major	O
complication	O
in	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
,	O
especially	O
in	O
those	O
with	O
obesity	B:C0028754
.	O

Plasma	B:C0032105
soluble	O
low	O
density	I:C1307867
lipoprotein	I:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
with	I:C1307867
11	I:C1307867
ligand	I:C1307867
-	I:C1307867
binding	I:C1307867
repeats	I:C1307867
(	O
sLR11	O
)	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
atherosclerosis	O
and	O
has	O
been	O
linked	O
to	O
the	O
metabolism	O
of	O
triglyceride	O
-	I:C0023820
rich	I:C0023820
lipoproteins	I:C0023820
,	O
adiposity	O
,	O
and	O
vascular	O
complications	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Plasma	O
soluble	O
low	B:C1307867
density	I:C1307867
lipoprotein	I:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
with	I:C1307867
11	I:C1307867
ligand	I:C1307867
-	I:C1307867
binding	I:C1307867
repeats	I:C1307867
(	O
sLR11	O
)	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
atherosclerosis	O
and	O
has	O
been	O
linked	O
to	O
the	O
metabolism	O
of	O
triglyceride	O
-	I:C0023820
rich	I:C0023820
lipoproteins	I:C0023820
,	O
adiposity	O
,	O
and	O
vascular	O
complications	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Plasma	O
soluble	O
low	O
density	I:C1307867
lipoprotein	I:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
with	I:C1307867
11	I:C1307867
ligand	I:C1307867
-	I:C1307867
binding	I:C1307867
repeats	I:C1307867
(	O
sLR11	B:C1307867
)	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
atherosclerosis	O
and	O
has	O
been	O
linked	O
to	O
the	O
metabolism	O
of	O
triglyceride	O
-	I:C0023820
rich	I:C0023820
lipoproteins	I:C0023820
,	O
adiposity	O
,	O
and	O
vascular	O
complications	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Plasma	O
soluble	O
low	O
density	I:C1307867
lipoprotein	I:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
with	I:C1307867
11	I:C1307867
ligand	I:C1307867
-	I:C1307867
binding	I:C1307867
repeats	I:C1307867
(	O
sLR11	O
)	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
atherosclerosis	B:C0004153
and	O
has	O
been	O
linked	O
to	O
the	O
metabolism	O
of	O
triglyceride	O
-	I:C0023820
rich	I:C0023820
lipoproteins	I:C0023820
,	O
adiposity	O
,	O
and	O
vascular	O
complications	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Plasma	O
soluble	O
low	O
density	I:C1307867
lipoprotein	I:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
with	I:C1307867
11	I:C1307867
ligand	I:C1307867
-	I:C1307867
binding	I:C1307867
repeats	I:C1307867
(	O
sLR11	O
)	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
atherosclerosis	O
and	O
has	O
been	O
linked	O
to	O
the	O
metabolism	B:C0025519
of	O
triglyceride	O
-	I:C0023820
rich	I:C0023820
lipoproteins	I:C0023820
,	O
adiposity	O
,	O
and	O
vascular	O
complications	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Plasma	O
soluble	O
low	O
density	I:C1307867
lipoprotein	I:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
with	I:C1307867
11	I:C1307867
ligand	I:C1307867
-	I:C1307867
binding	I:C1307867
repeats	I:C1307867
(	O
sLR11	O
)	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
atherosclerosis	O
and	O
has	O
been	O
linked	O
to	O
the	O
metabolism	O
of	O
triglyceride	B:C0023820
-	I:C0023820
rich	I:C0023820
lipoproteins	I:C0023820
,	O
adiposity	O
,	O
and	O
vascular	O
complications	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Plasma	O
soluble	O
low	O
density	I:C1307867
lipoprotein	I:C1307867
receptor	I:C1307867
-	I:C1307867
relative	I:C1307867
with	I:C1307867
11	I:C1307867
ligand	I:C1307867
-	I:C1307867
binding	I:C1307867
repeats	I:C1307867
(	O
sLR11	O
)	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
atherosclerosis	O
and	O
has	O
been	O
linked	O
to	O
the	O
metabolism	O
of	O
triglyceride	O
-	I:C0023820
rich	I:C0023820
lipoproteins	I:C0023820
,	O
adiposity	O
,	O
and	O
vascular	O
complications	O
in	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

We	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
diet	O
-	O
induced	O
weight	O
loss	O
on	O
plasma	B:C0032105
sLR11	O
levels	O
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

We	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
diet	O
-	O
induced	O
weight	O
loss	O
on	O
plasma	O
sLR11	B:C1307867
levels	O
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

We	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
diet	O
-	O
induced	O
weight	O
loss	O
on	O
plasma	O
sLR11	O
levels	O
in	O
overweight	O
and	O
obese	B:C0028754
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

We	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
diet	O
-	O
induced	O
weight	O
loss	O
on	O
plasma	O
sLR11	O
levels	O
in	O
overweight	O
and	O
obese	O
individuals	B:C0237401
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

We	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
diet	O
-	O
induced	O
weight	O
loss	O
on	O
plasma	O
sLR11	O
levels	O
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

Plasma	B:C0032105
sLR11	O
levels	O
were	O
determined	O
in	O
64	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
and	O
BMI	O
>	O
27	O
kg	O
/	O
m	O
(	O
2	O
)	O
before	O
and	O
after	O
a	O
20	O
-	O
week	O
weight	O
loss	I:C0012167
diet	I:C0012167
.	O

Plasma	O
sLR11	B:C1307867
levels	O
were	O
determined	O
in	O
64	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
and	O
BMI	O
>	O
27	O
kg	O
/	O
m	O
(	O
2	O
)	O
before	O
and	O
after	O
a	O
20	O
-	O
week	O
weight	O
loss	I:C0012167
diet	I:C0012167
.	O

Plasma	O
sLR11	O
levels	O
were	O
determined	O
in	O
64	O
individuals	B:C0237401
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
and	O
BMI	O
>	O
27	O
kg	O
/	O
m	O
(	O
2	O
)	O
before	O
and	O
after	O
a	O
20	O
-	O
week	O
weight	O
loss	I:C0012167
diet	I:C0012167
.	O

Plasma	O
sLR11	O
levels	O
were	O
determined	O
in	O
64	O
individuals	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
and	O
BMI	O
>	O
27	O
kg	O
/	O
m	O
(	O
2	O
)	O
before	O
and	O
after	O
a	O
20	O
-	O
week	O
weight	O
loss	I:C0012167
diet	I:C0012167
.	O

Plasma	O
sLR11	O
levels	O
were	O
determined	O
in	O
64	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
and	O
BMI	B:C1305855
>	O
27	O
kg	O
/	O
m	O
(	O
2	O
)	O
before	O
and	O
after	O
a	O
20	O
-	O
week	O
weight	O
loss	I:C0012167
diet	I:C0012167
.	O

Plasma	O
sLR11	O
levels	O
were	O
determined	O
in	O
64	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
and	O
BMI	O
>	O
27	O
kg	O
/	O
m	O
(	O
2	O
)	O
before	O
and	O
after	O
a	O
20	O
-	O
week	O
weight	B:C0012167
loss	I:C0012167
diet	I:C0012167
.	O

As	O
a	O
reference	O
,	O
sLR11	B:C1307867
levels	O
were	O
also	O
determined	O
in	O
64	O
healthy	O
,	O
non	O
-	O
obese	O
controls	O
,	O
matched	O
as	O
a	O
group	O
for	O
age	O
and	O
sex	O
.	O

Median	O
plasma	B:C0032105
sLR11	O
levels	O
of	O
the	O
type	O
2	I:C0011860
diabetes	I:C0011860
study	O
-	I:C2348561
group	I:C2348561
at	O
baseline	O
(	O
15.4	O
ng/mL	O
(	O
IQR	O
12.9	O
-	O
19.5	O
)	O
)	O
were	O
higher	O
than	O
in	O
controls	O
(	O
10.2	O
(	O
IQR	O
:	O
8.7	O
-	O
12.2	O
)	O
ng/	O
mL	O
;	O
p	O
=	O
0.001	O
)	O
.	O

Median	O
plasma	O
sLR11	B:C1307867
levels	O
of	O
the	O
type	O
2	I:C0011860
diabetes	I:C0011860
study	O
-	I:C2348561
group	I:C2348561
at	O
baseline	O
(	O
15.4	O
ng/mL	O
(	O
IQR	O
12.9	O
-	O
19.5	O
)	O
)	O
were	O
higher	O
than	O
in	O
controls	O
(	O
10.2	O
(	O
IQR	O
:	O
8.7	O
-	O
12.2	O
)	O
ng/	O
mL	O
;	O
p	O
=	O
0.001	O
)	O
.	O

Median	O
plasma	O
sLR11	O
levels	O
of	O
the	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
study	O
-	I:C2348561
group	I:C2348561
at	O
baseline	O
(	O
15.4	O
ng/mL	O
(	O
IQR	O
12.9	O
-	O
19.5	O
)	O
)	O
were	O
higher	O
than	O
in	O
controls	O
(	O
10.2	O
(	O
IQR	O
:	O
8.7	O
-	O
12.2	O
)	O
ng/	O
mL	O
;	O
p	O
=	O
0.001	O
)	O
.	O

Median	O
plasma	O
sLR11	O
levels	O
of	O
the	O
type	O
2	I:C0011860
diabetes	I:C0011860
study	B:C2348561
-	I:C2348561
group	I:C2348561
at	O
baseline	O
(	O
15.4	O
ng/mL	O
(	O
IQR	O
12.9	O
-	O
19.5	O
)	O
)	O
were	O
higher	O
than	O
in	O
controls	O
(	O
10.2	O
(	O
IQR	O
:	O
8.7	O
-	O
12.2	O
)	O
ng/	O
mL	O
;	O
p	O
=	O
0.001	O
)	O
.	O

The	O
diet	B:C0012155
resulted	O
in	O
a	O
weight	O
loss	I:C1262477
of	O
9.7	O
±	O
5.2	O
%	O
(	O
p	O
=	O
0.001	O
)	O
and	O
improved	O
Cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
.	O

The	O
diet	O
resulted	O
in	O
a	O
weight	B:C1262477
loss	I:C1262477
of	O
9.7	O
±	O
5.2	O
%	O
(	O
p	O
=	O
0.001	O
)	O
and	O
improved	O
Cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
.	O

The	O
diet	O
resulted	O
in	O
a	O
weight	O
loss	I:C1262477
of	O
9.7	O
±	O
5.2	O
%	O
(	O
p	O
=	O
0.001	O
)	O
and	O
improved	O
Cardiovascular	B:C0007222
disease	I:C0007222
risk	O
factors	I:C0035648
.	O

The	O
diet	O
resulted	O
in	O
a	O
weight	O
loss	I:C1262477
of	O
9.7	O
±	O
5.2	O
%	O
(	O
p	O
=	O
0.001	O
)	O
and	O
improved	O
Cardiovascular	O
disease	I:C0007222
risk	B:C0035648
factors	I:C0035648
.	O

sLR11	B:C1307867
levels	O
were	O
reduced	O
to	O
13.3	O
ng/mL	O
(	O
IQR	O
11.0	O
-	O
17.1	O
;	O
p	O
=	O
0.001	O
)	O
.	O

Changes	O
in	O
sLR11	B:C1307867
levels	O
positively	O
associated	O
with	O
changes	O
in	O
non-HDL	O
cholesterol	I:C0729627
(	O
B	O
=	O
1.54	O
,	O
R(	O
2	O
)	O
=	O
0.17	O
,	O
p	O
=	O
0.001	O
)	O
and	O
HbA1c	O
(	O
B	O
=	O
0.07	O
,	O
R(	O
2	O
)	O
=	O
0.11	O
,	O
p	O
=	O
0.007	O
)	O
,	O
but	O
not	O
with	O
weight	O
loss	I:C1262477
(	O
B	O
=	O
0.04	O
,	O
R(	O
2	O
)	O
=	O
0.05	O
,	O
p	O
=	O
0.076	O
)	O
.	O

Changes	O
in	O
sLR11	O
levels	O
positively	O
associated	O
with	O
changes	O
in	O
non-HDL	B:C0729627
cholesterol	I:C0729627
(	O
B	O
=	O
1.54	O
,	O
R(	O
2	O
)	O
=	O
0.17	O
,	O
p	O
=	O
0.001	O
)	O
and	O
HbA1c	O
(	O
B	O
=	O
0.07	O
,	O
R(	O
2	O
)	O
=	O
0.11	O
,	O
p	O
=	O
0.007	O
)	O
,	O
but	O
not	O
with	O
weight	O
loss	I:C1262477
(	O
B	O
=	O
0.04	O
,	O
R(	O
2	O
)	O
=	O
0.05	O
,	O
p	O
=	O
0.076	O
)	O
.	O

Changes	O
in	O
sLR11	O
levels	O
positively	O
associated	O
with	O
changes	O
in	O
non-HDL	O
cholesterol	I:C0729627
(	O
B	O
=	O
1.54	O
,	O
R(	O
2	O
)	O
=	O
0.17	O
,	O
p	O
=	O
0.001	O
)	O
and	O
HbA1c	B:C0019018
(	O
B	O
=	O
0.07	O
,	O
R(	O
2	O
)	O
=	O
0.11	O
,	O
p	O
=	O
0.007	O
)	O
,	O
but	O
not	O
with	O
weight	O
loss	I:C1262477
(	O
B	O
=	O
0.04	O
,	O
R(	O
2	O
)	O
=	O
0.05	O
,	O
p	O
=	O
0.076	O
)	O
.	O

Changes	O
in	O
sLR11	O
levels	O
positively	O
associated	O
with	O
changes	O
in	O
non-HDL	O
cholesterol	I:C0729627
(	O
B	O
=	O
1.54	O
,	O
R(	O
2	O
)	O
=	O
0.17	O
,	O
p	O
=	O
0.001	O
)	O
and	O
HbA1c	O
(	O
B	O
=	O
0.07	O
,	O
R(	O
2	O
)	O
=	O
0.11	O
,	O
p	O
=	O
0.007	O
)	O
,	O
but	O
not	O
with	O
weight	B:C1262477
loss	I:C1262477
(	O
B	O
=	O
0.04	O
,	O
R(	O
2	O
)	O
=	O
0.05	O
,	O
p	O
=	O
0.076	O
)	O
.	O

The	O
changes	O
in	O
non-HDL	B:C0729627
cholesterol	I:C0729627
and	O
HbA1	O
c	I:C0019018
together	O
explained	O
24	O
%	O
of	O
the	O
variance	O
of	O
sLR11	O
reduction	O
(	O
p	O
=	O
0.001	O
)	O
.	O

The	O
changes	O
in	O
non-HDL	O
cholesterol	I:C0729627
and	O
HbA1	B:C0019018
c	I:C0019018
together	O
explained	O
24	O
%	O
of	O
the	O
variance	O
of	O
sLR11	O
reduction	O
(	O
p	O
=	O
0.001	O
)	O
.	O

The	O
changes	O
in	O
non-HDL	O
cholesterol	I:C0729627
and	O
HbA1	O
c	I:C0019018
together	O
explained	O
24	O
%	O
of	O
the	O
variance	O
of	O
sLR11	B:C1307867
reduction	O
(	O
p	O
=	O
0.001	O
)	O
.	O

Weight	B:C0012167
loss	I:C0012167
dieting	I:C0012167
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
resulted	O
in	O
a	O
reduction	O
in	O
plasma	O
sLR11	O
levels	O
that	O
was	O
associated	O
with	O
improvements	O
in	O
lipid	O
-	I:C0200382
profile	I:C0200382
and	O
glycemic	O
state	O
.	O

Weight	O
loss	I:C0012167
dieting	I:C0012167
in	O
overweight	O
and	O
obese	B:C0028754
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
resulted	O
in	O
a	O
reduction	O
in	O
plasma	O
sLR11	O
levels	O
that	O
was	O
associated	O
with	O
improvements	O
in	O
lipid	O
-	I:C0200382
profile	I:C0200382
and	O
glycemic	O
state	O
.	O

Weight	O
loss	I:C0012167
dieting	I:C0012167
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
resulted	O
in	O
a	O
reduction	O
in	O
plasma	O
sLR11	O
levels	O
that	O
was	O
associated	O
with	O
improvements	O
in	O
lipid	O
-	I:C0200382
profile	I:C0200382
and	O
glycemic	O
state	O
.	O

Weight	O
loss	I:C0012167
dieting	I:C0012167
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
resulted	O
in	O
a	O
reduction	O
in	O
plasma	B:C0032105
sLR11	O
levels	O
that	O
was	O
associated	O
with	O
improvements	O
in	O
lipid	O
-	I:C0200382
profile	I:C0200382
and	O
glycemic	O
state	O
.	O

Weight	O
loss	I:C0012167
dieting	I:C0012167
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
resulted	O
in	O
a	O
reduction	O
in	O
plasma	O
sLR11	B:C1307867
levels	O
that	O
was	O
associated	O
with	O
improvements	O
in	O
lipid	O
-	I:C0200382
profile	I:C0200382
and	O
glycemic	O
state	O
.	O

Weight	O
loss	I:C0012167
dieting	I:C0012167
in	O
overweight	O
and	O
obese	O
individuals	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
resulted	O
in	O
a	O
reduction	O
in	O
plasma	O
sLR11	O
levels	O
that	O
was	O
associated	O
with	O
improvements	O
in	O
lipid	B:C0200382
-	I:C0200382
profile	I:C0200382
and	O
glycemic	O
state	O
.	O

